Öz

Amaç

Çalışmamızın amacı, gebeleri retrospektif olarak değerlendirerek koronavirüs hastalığı (COVID) pnömonisi ile mortalite, hastaların bağışıklama durumları arasındaki ilişkiyi ortaya koymak ve ilk ekstrakorporeal membran oksijenasyonu (ECMO) deneyimlerimizi sunmaktır.

Gereç ve Yöntem

Araştırma, 1 Mart 2020 ile 1 Aralık 2021 tarihleri arasında yoğun bakım ünitesinde takip ve tedavi edilen toplam 37 gebe/postpartum COVID-2019 olgusunun dosyaları taranarak gerçekleştirildi. Hastaların yaşları, sistemik komorbiditeleri, aşı detayları, klinik ve laboratuvar özellikleri kaydedildi ve analiz edildi. Hastalar sağkalanlar (grup 1; n=17) ve eksitus olanlar (grup 2; n=20) olarak 2 gruba ayrıldı ve sonuçlar istatistiksel olarak karşılaştırıldı.

Bulgular

Çalışmamızda 37 hastanın 17’si (%45,9) hayatta kaldı (grup 1) ve 20’si (%54,1) öldü (grup 2). Medyan gebelik haftası 31 hafta olup, yoğun bakım yatış süresi 9 gündü. Yoğun bakım ünitesine yatış günü [polimeraz zincir reaksiyonu (PZR) pozitifliğinin (+) kaçıncı günü] ve sezeryan süresi [polimeraz zincir reaksiyonu (PZR) pozitifliğinin (+) kaçıncı günü] ortalama 8. gündü. Dokuz (%24) hasta ECMO ve mekanik ventilasyon desteğinde takip edildi, bu hastaların 6’sı (%66,6) eksitus oldu. Üç (%33,3) sağ kalan hasta sekelsiz taburcu edildi. Otuz yedi gebe/postpartum hastanın 36’sı aşısızdı.

Sonuç

Gebelerde aşı ile bağışıklamaya öncelik verilmelidir, ECMO COVID-19(+) gebe hastalarda oksijenlenmenin düzenlenmesinde etkili olabilir.

Anahtar Kelimeler: COVID-19, ECMO, gebelik, aşı, YBÜ

Referanslar

  1. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33:S390-7.
  2. Alserehi H, Wali G, Alshukairi A, Alraddadi B. Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016;16:105.
  3. Landt S, Sina F, Kimmig R, Schmidt M. H1N1 - Risikofaktor Schwangerschaft [H1N1--pregnancy as risk factor]. Z Geburtshilfe Neonatol. 2010;214:48-51.
  4. World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from: URL:https://www.who.int/publications/i/item/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19). Accessed April 1, 2020.
  5. Eman A, Balaban O, Kocayiğit H, Süner KÖ, Cırdı Y, Erdem AF. Maternal and Neonatal Outcomes of Critically Ill Pregnant and Puerperal Patients Diagnosed with COVID-19 Disease: Retrospective Comparative Study. J Korean Med Sci. 2021;36:e309.
  6. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
  7. Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020;2:100118.
  8. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:769-75.
  9. Tekbali A, Grünebaum A, Saraya A, McCullough L, Bornstein E, Chervenak FA. Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York. Am J Obstet Gynecol. 2020;223:126-7.
  10. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175:817-26.
  11. Mark EG, McAleese S, Golden WC, Gilmore MM, Sick-Samuels A, Curless MS, et al. Coronavirus Disease 2019 in Pregnancy and Outcomes Among Pregnant Women and Neonates: A Literature Review. Pediatr Infect Dis J. 2021;40:473-8.
  12. Siqueira TS, de Souza EKG, Martins-Filho PR, Silva JRS, Gurgel RQ, Cuevas LE, et al. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: a nationwide population-based cohort study. J Travel Med. 2022;29:taab199.
  13. Hessami K, Homayoon N, Hashemi A, Vafaei H, Kasraeian M, Asadi N. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. J Matern Fetal Neonatal Med. 2022;35:2936-41.
  14. Takemoto MLS, Menezes MO, Andreucci CB, Knobel R, Sousa LAR, Katz L, et al. Maternal mortality and COVID-19. J Matern Fetal Neonatal Med. 2022;35:2355-61.
  15. Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020;56:15-27.
  16. Douglass KM, Strobel KM, Richley M, Mok T, de St Maurice A, Fajardo V, et al. Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support: A Case Series. Am J Perinatol. 2021;38:82-7.
  17. Barrantes JH, Ortoleva J, O’Neil ER, Suarez EE, Beth Larson S, Rali AS, et al. Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation. ASAIO J. 2021;67:132-6.
  18. Bauer ME, Chiware R, Pancaro C. Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports. Anesth Analg. 2020;131:e22-4.
  19. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20.
  20. University of Oxford. The Recovery trial.https://www.recoverytrial.net/. Accessed March4, 2021.
  21. Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RAC, Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42:829-40.
  22. Magala Ssekandi A, Sserwanja Q, Olal E, Kawuki J, Bashir Adam M. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence. J Multidiscip Healthc. 2021;14:659-63.
  23. Mariotti V, Marconi AM, Pardi G. Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med. 2004;16 Suppl 2:5-7.
  24. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-7.
  25. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324-9.
  26. Bookstein Peretz S, Regev N, Novick L, Nachshol M, Goffer E, Ben-David A, et al. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine. Ultrasound Obstet Gynecol. 2021;58:450-6.
  27. Rasmussen SA, Jamieson DJ. COVID-19 and Pregnancy. Infect Dis Clin North Am. 2022;36:423-33.

Nasıl atıf yapılır?

1.
Tekin S, Adıyeke E, Öngel EE, Bakan N. COVID-19 ile Enfekte Gebelerin Sağkalımını Etkileyen Faktörler ve İlk Ekstrakorporeal Membran Oksijenasyonu Sonuçlarımız. Turk J Intensive Care. 2024;22(3):161-169. https://doi.org/10.4274/tybd.galenos.2023.41275